Stay updated on CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedPage revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check82 days agoChange DetectedThe page now displays a site-wide government funding notice and updates the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check89 days agoChange DetectedUI and metadata updates: a Show glossary option was added, the page now displays 'Last Update Submitted that Met QC Criteria,' and headers include 'No FEAR Act Data' and 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page.